Clinical Trials Browser

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02294084 2018-07-16

Sita01

Phase 4 Completed

30 enrolled

Neoplasms, Adipose Tissue

NCT02941445 2016-10-21

Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss

Phase 4 Completed

24 enrolled

Body Weight, Polycystic Ovary Syndrome

NCT02475499 2016-03-14

Incretin-based Drugs and Pancreatic Cancer

Completed

886,172 enrolled

Gastrointestinal

Diabetes Mellitus, Type 2, Pancreatic Neoplasms

NCT00418366 2015-08-19

A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008)

Phase 1 Completed

24 enrolled

GenitourinaryLymphoid

Kidney Failure, Chronic, Lymphoma, Follicular, Renal Insufficiency

NCT02493959 2015-07-10

Degradation of the Anorexic Hormone Peptide YY

Phase EARLY_PHASE1 Completed

8 enrolled

Endocrine

Multiple Endocrine Neoplasia Type 1

NCT01588587 2012-10-19

DPP-IV Inhibitors Underlying Mechanism of Cancer in Diabetic Patients

Unknown

500 enrolled

Diabetes Mellitus, Type 2

Clinical Trials

SGLT2i/DPPi

A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas

Sitagliptin or BeiDouGen Capsule Improve the Pregnancy Outcome in Patients with PCOS

High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHD

Effect of Sitagliptin on Polycystic Ovarian Syndrome Patients

Comparing the Effect of Sitagliptin/Metformin and Metformin in PCOS Patients

METNODTHYR

The Effect of Dipeptidyl Peptidase 4 Inhibition on Growth Hormone Secretion in Women With Polycystic Ovarian Syndrome

Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant